CLINICAL TRIALS PROFILE FOR PREVNAR 13
✉ Email this page to a colleague
All Clinical Trials for PREVNAR 13
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00227188 ↗ | Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain. | Completed | Pfizer | 2003-05-01 | The aim of this study is to evaluate the postlicensure effectiveness of Prevnar in the prevention of IPD in the Spanish paediatric population (children younger than 5 years) | |
NCT00323557 ↗ | Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients | Completed | Bayer | Phase 2 | 2004-06-01 | The goal of this clinical research study is to see if Leukine(R) (sargramostim) improves the effectiveness of the pneumococcal vaccine, a medicine used to prevent pneumococcal pneumonia, in patients with chronic lymphocytic leukemia (CLL). |
NCT00323557 ↗ | Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients | Completed | M.D. Anderson Cancer Center | Phase 2 | 2004-06-01 | The goal of this clinical research study is to see if Leukine(R) (sargramostim) improves the effectiveness of the pneumococcal vaccine, a medicine used to prevent pneumococcal pneumonia, in patients with chronic lymphocytic leukemia (CLL). |
NCT00390130 ↗ | Does the Order in Which Vaccines Are Administered Affect Pain Response? | Completed | The Hospital for Sick Children | Phase 4 | 2006-07-01 | The objective of this study is to determine whether there should be a predetermined sequence recommended for administering these two vaccines, with the less painful vaccine being given first. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PREVNAR 13
Condition Name
Clinical Trial Locations for PREVNAR 13
Trials by Country
Clinical Trial Progress for PREVNAR 13
Clinical Trial Phase
Clinical Trial Sponsors for PREVNAR 13
Sponsor Name